Intrinsic Type 1 Interferon (IFN1) Profile of Uncultured Human Bone Marrow CD45lowCD271+ Multipotential Stromal Cells (BM-MSCs): The Impact of Donor Age, Culture Expansion and IFNα and IFNβ Stimulation

Skeletal aging is associated with reduced proliferative potential of bone marrow (BM) multipotential stromal cells (MSCs). Recent data suggest the involvement of type 1 interferon (IFN1) signalling in hematopoietic stem cell (HSC) senescence. Considering that BM-HSCs and BM-MSCs share the same BM niche, we investigated IFN1 expression profile in human BM-MSCs in relation to donor age, culture-expansion and IFN1 (α and β) stimulation. Fluorescence-activated cell sorting was used to purify uncultured BM-MSCs from younger (19–41, n = 6) and older (59–89, n = 6) donors based on the CD45lowCD271+ phenotype, and hematopoietic-lineage cells (BM-HLCs, CD45+CD271−) were used as controls. Gene expression was analysed using integrated circuits arrays in sorted fractions as well as cultured/stimulated BM-MSCs and Y201/Y202 immortalised cell lines. IFN1 stimulation led to BM-MSC growth arrest and upregulation of many IFN1-stimulated genes (ISGs), with IFNβ demonstrating stronger effects. Uncultured MSCs were characterised by a moderate-level ISG expression similar to Y201 cells. Age-related changes in ISG expression were negligible in BM-MSCs compared to BM-HLCs, and intracellular reactive oxygen species (ROS) levels in BM-MSCs did not significantly correlate with donor age. Antiaging genes Klotho and SIRT6 correlated with more ISGs in BM-MSCs than in BM-HLCs. In patients with osteoarthritis (OA), BM-MSCs expressed considerably lower levels of several ISGs, indicating that their IFN1 signature is affected in a pathological condition. In summary, BM-MSCs possess homeostatic IFN1 gene expression signature in health, which is sensitive to in vitro culture and external IFN1 stimulation. IFN signalling may facilitate in vivo BM-MSC responses to DNA damage and combating senescence and aberrant immune activation.

[1]  P. Sfikakis,et al.  DNA Damage Response and Oxidative Stress in Systemic Autoimmunity , 2019, International journal of molecular sciences.

[2]  C. Richardson,et al.  The Ubiquitin-Specific Protease 18 Promotes Hepatitis C Virus Production by Increasing Viral Infectivity , 2019, Mediators of inflammation.

[3]  P. Giannoudis,et al.  The Biological Fitness of Bone Progenitor Cells in Reamer/Irrigator/Aspirator Waste. , 2019, The Journal of bone and joint surgery. American volume.

[4]  K. O'Connor.  Molecular Profiles of Cell-to-Cell Variation in the Regenerative Potential of Mesenchymal Stromal Cells , 2019, Stem cells international.

[5]  P. Giannoudis,et al.  The Analysis of In Vivo Aging in Human Bone Marrow Mesenchymal Stromal Cells Using Colony-Forming Unit-Fibroblast Assay and the CD45lowCD271+ Phenotype , 2019, Stem cells international.

[6]  Samuel L. Wolock,et al.  Mapping Distinct Bone Marrow Niche Populations and Their Differentiation Paths. , 2019, Cell reports.

[7]  Zhi-ming Ni,et al.  The Role of Interferon Regulatory Factor 5 in Macrophage Inflammation During Osteoarthritis , 2019, Inflammation.

[8]  L. Pangrazzi,et al.  The impact of oxidative stress, inflammation, and senescence on the maintenance of immunological memory in the bone marrow in old age , 2019, Bioscience reports.

[9]  P. Giannoudis,et al.  The simultaneous analysis of mesenchymal stem cells and early osteocytes accumulation in osteoarthritic femoral head sclerotic bone , 2019, Rheumatology.

[10]  S. Khosla,et al.  Cellular senescence in bone. , 2019, Bone.

[11]  S. Jazwinski,et al.  Examination of the Dimensions of Biological Age , 2019, Front. Genet..

[12]  Austin J. Ramme,et al.  Age-related inflammation triggers skeletal stem/progenitor cell dysfunction , 2019, Proceedings of the National Academy of Sciences.

[13]  Avi Ma’ayan,et al.  Engineering a haematopoietic stem cell niche by revitalizing mesenchymal stromal cells , 2019, Nature Cell Biology.

[14]  S. Crippa,et al.  An early‐senescence state in aged mesenchymal stromal cells contributes to hematopoietic stem and progenitor cell clonogenic impairment through the activation of a pro‐inflammatory program , 2019, Aging cell.

[15]  D. Kehler,et al.  Age-related disease burden as a measure of population ageing. , 2019, The Lancet. Public health.

[16]  J. V. van Deursen,et al.  Inhibition of ‘jumping genes’ promotes healthy ageing , 2019, Nature.

[17]  Jiacan Su,et al.  RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation , 2018, Bone Research.

[18]  E. Jones,et al.  T cell immunomodulation by clinically used allogeneic human cancellous bone fragments: a potential novel immunotherapy tool , 2018, Scientific Reports.

[19]  A. Poltorak,et al.  Host-Intrinsic Interferon Status in Infection and Immunity. , 2018, Trends in molecular medicine.

[20]  Zhijian J. Chen,et al.  The cGAS–cGAMP–STING pathway connects DNA damage to inflammation, senescence, and cancer , 2018, The Journal of experimental medicine.

[21]  Y. Sonoda,et al.  TGF-β Signaling Accelerates Senescence of Human Bone-Derived CD271 and SSEA-4 Double-Positive Mesenchymal Stromal Cells , 2018, Stem cell reports.

[22]  D. Dorsett,et al.  A Cell-Intrinsic Interferon-like Response Links Replication Stress to Cellular Aging Caused by Progerin , 2018, Cell reports.

[23]  C. Wen,et al.  Do immune cells lead the way in subchondral bone disturbance in osteoarthritis? , 2017, Progress in biophysics and molecular biology.

[24]  C. Rice,et al.  Intrinsic Immunity Shapes Viral Resistance of Stem Cells , 2017, Cell.

[25]  S. Soneji,et al.  Human Primary Bone Marrow Mesenchymal Stromal Cells and Their in vitro Progenies Display Distinct Transcriptional Profile Signatures , 2017, Scientific Reports.

[26]  J. Liesveld,et al.  Bone Marrow–Derived Mesenchymal Stem Cells From Patients With Systemic Lupus Erythematosus Have a Senescence‐Associated Secretory Phenotype Mediated by a Mitochondrial Antiviral Signaling Protein–Interferon‐β Feedback Loop , 2017, Arthritis & rheumatology.

[27]  U. Kneser,et al.  Age‐dependent alterations in osteoblast and osteoclast activity in human cancellous bone , 2017, Journal of cellular and molecular medicine.

[28]  A. Gross,et al.  The IFN-1 > BID > ROS pathway: Linking DNA damage with HSPC malfunction , 2017, Cell cycle.

[29]  G. Schreiber.  The molecular basis for differential type I interferon signaling , 2017, The Journal of Biological Chemistry.

[30]  C. Franceschi,et al.  Inflammaging and ‘Garb-aging’ , 2017, Trends in Endocrinology & Metabolism.

[31]  Susan M. Schlenner,et al.  Hematopoietic Stem Cell Niches Produce Lineage-Instructive Signals to Control Multipotent Progenitor Differentiation. , 2016, Immunity.

[32]  A. F. Stewart,et al.  DNA Damage-Induced HSPC Malfunction Depends on ROS Accumulation Downstream of IFN-1 Signaling and Bid Mobilization. , 2016, Cell stem cell.

[33]  M. Manz,et al.  Inflamm-Aging of Hematopoiesis, Hematopoietic Stem Cells, and the Bone Marrow Microenvironment , 2016, Front. Immunol..

[34]  Dong-er Zhang,et al.  Multiple functions of USP18 , 2016, Cell Death & Disease.

[35]  Yaojiong Wu,et al.  Mesenchymal stem cell subpopulations: phenotype, property and therapeutic potential , 2016, Cellular and Molecular Life Sciences.

[36]  Kenneth G. C. Smith,et al.  Leucocyte subset-specific type 1 interferon signatures in SLE and other immune-mediated diseases , 2016, RMD Open.

[37]  P. Cerri,et al.  Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells , 2015, BioMed research international.

[38]  P. Genever,et al.  Multiparameter Analysis of Human Bone Marrow Stromal Cells Identifies Distinct Immunomodulatory and Differentiation-Competent Subtypes , 2015, Stem cell reports.

[39]  C. Lengner,et al.  DNA-damage-induced type I interferon promotes senescence and inhibits stem cell function. , 2015, Cell reports.

[40]  H. Yokosawa,et al.  ISG15 regulates RANKL-induced osteoclastogenic differentiation of RAW264 cells. , 2015, Biological & pharmaceutical bulletin.

[41]  A. Kruger,et al.  Gene expression profiling of replicative and induced senescence , 2014, Cell cycle.

[42]  C. Rice,et al.  Interferon-stimulated genes: a complex web of host defenses. , 2014, Annual review of immunology.

[43]  Wei Tan,et al.  p53/p21 Pathway Involved in Mediating Cellular Senescence of Bone Marrow-Derived Mesenchymal Stem Cells from Systemic Lupus Erythematosus Patients , 2013, Clinical & developmental immunology.

[44]  Manuel Serrano,et al.  The Hallmarks of Aging , 2013, Cell.

[45]  Zhijian J. Chen,et al.  Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway , 2013, Science.

[46]  P. Giannoudis,et al.  Transcriptional profile of native CD271+ multipotential stromal cells: evidence for multiple fates, with prominent osteogenic and Wnt pathway signaling activity. , 2012, Arthritis and rheumatism.

[47]  M. Eijken,et al.  IFNβ impairs extracellular matrix formation leading to inhibition of mineralization by effects in the early stage of human osteoblast differentiation , 2012, Journal of cellular physiology.

[48]  G. Fishman,et al.  Connexin-43 prevents hematopoietic stem cell senescence through transfer of reactive oxygen species to bone marrow stromal cells , 2012, Proceedings of the National Academy of Sciences.

[49]  D. Levy,et al.  Constitutive type I interferon modulates homeostatic balance through tonic signaling. , 2012, Immunity.

[50]  M. Ehinger,et al.  CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization. , 2011, Blood.

[51]  F. Liu,et al.  Klotho suppresses RIG-I-mediated senescence-associated inflammation , 2011, Nature Cell Biology.

[52]  H. Bühring,et al.  Prospective isolation of human MSC. , 2011, Best practice & research. Clinical haematology.

[53]  L. Sensébé,et al.  Bone Marrow Mesenchymal Stem Cells: Biological Properties and Their Role in Hematopoiesis and Hematopoietic Stem Cell Transplantation , 2011, Stem Cell Reviews and Reports.

[54]  Ben D. MacArthur,et al.  Mesenchymal and haematopoietic stem cells form a unique bone marrow niche , 2010, Nature.

[55]  P. Emery,et al.  Large-scale extraction and characterization of CD271+ multipotential stromal cells from trabecular bone in health and osteoarthritis: implications for bone regeneration strategies based on uncultured or minimally cultured multipotential stromal cells. , 2010, Arthritis and rheumatism.

[56]  L. Xing,et al.  Functions of RANKL/RANK/OPG in bone modeling and remodeling. , 2008, Archives of biochemistry and biophysics.

[57]  F. Lafeber,et al.  Role of interleukin-7 in degenerative and inflammatory joint diseases , 2008, Arthritis research & therapy.

[58]  N. Fortunel,et al.  A sub-population of high proliferative potential-quiescent human mesenchymal stem cells is under the reversible control of interferon α/β , 2007, Leukemia.

[59]  T. Mittlmeier,et al.  Elevated IL‐6 levels in the synovial fluid of osteoarthritis patients stem from plasma cells , 2007, Scandinavian journal of rheumatology.

[60]  T. Nagasawa,et al.  Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. , 2006, Immunity.

[61]  V. Pascual,et al.  Type I interferon in systemic lupus erythematosus and other autoimmune diseases. , 2006, Immunity.

[62]  Hiroshi Takayanagi,et al.  Interplay between interferon and other cytokine systems in bone metabolism , 2005, Immunological reviews.

[63]  S. Berven,et al.  Effects of interferon alpha on human osteoprogenitor cell growth and differentiation in vitro , 1999, Journal of cellular biochemistry.

[64]  S. Vaisrub,et al.  Cellular Senescence , 2019, Methods in Molecular Biology.

[65]  I. Weissman,et al.  Age-associated changes in human hematopoietic stem cells. , 2017, Seminars in hematology.

[66]  N. Fortunel,et al.  A sub-population of high proliferative potential-quiescent human mesenchymal stem cells is under the reversible control of interferon α/β , 2007, Leukemia.